Published on 31 Jan 2024 on Insider Monkey via Yahoo Finance
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript January 31, 2024
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75. TEVA isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Hello and welcome to the fourth quarter and full year 2023 Teva Pharmaceutical Industries earnings conference call. My name is Alex and I’ll be coordinating the call today. If you’d like to ask a question at the end of the presentation, you can press star followed by one on your telephone keypad. If you’d like to remove your question, you may press star followed by two. I’ll now hand it over to your host, Ran Meir, Head of Investor Relations. Please go ahead.